article Open AccessTop 1% cited
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · Vol. 24(9) · pp. 2206–2223
Aron Goldhirsch(European Institute of Oncology)Eric P. Winer(Harvard University Press)Alan S. Coates(University of Sydney)Richard D. Gelber(Harvard University Press)Martine Piccart(Institut Jules Bordet)Beat Thürlimann(Kantonsspital St. Gallen)Hans-Jörg Senn(University of St. Gallen)Kathy S. Albain(Loyola University Chicago)Fabrice AndréJonas Bergh(Karolinska Institutet)Hervé Bonnefoi(Université de Bordeaux)Denisse Bretel-MoralesHarold J. Burstein(Harvard University Press)Fátima CardosoMonica Castiglione‐Gertsch(University of Geneva)Alan S. Coates(University of Sydney)Marco ColleoniAlberto CostaGiuseppe CuriglianoNancy E. Davidson(University of Pittsburgh)Angelo Di LeoBent Ejlertsen(University of Copenhagen)John Forbes(University of Newcastle Australia)Richard D. Gelber(Harvard University Press)Michael Gnant(Medical University of Vienna)Aron Goldhirsch✉(European Institute of Oncology)Pamela J. Goodwin(University of Toronto)Paul E. GossJay R. Harris(Harvard University Press)Daniel F. Hayes(University of Michigan–Ann Arbor)Clifford A. Hudis(Memorial Sloan Kettering Cancer Center)James N. Ingle(WinnMed)Jacek Jassem(Gdańsk Medical University)Zefei JiangPer Karlsson(University of Gothenburg)Sibylle LoiblMonica Morrow(Memorial Sloan Kettering Cancer Center)Moïse NamerC. Kent Osborne(Baylor College of Medicine)Ann H. Partridge(Harvard University Press)Frédérique Penault‐LlorcaCharles M. Perou(University of North Carolina at Chapel Hill)Martine Piccart(Université Libre de Bruxelles)Kathleen I. Pritchard(University of Toronto)Emiel J. RutgersFelix SedlmayerSemiglazov VfZhi‐Ming Shao(Fudan University)Ian SmithBeat Thürlimann(Kantonsspital St. Gallen)Masakazu Toi(Kyoto University)Andrew Tutt(King's College London)Michael Untch(University of Göttingen)Giuseppe VialeToru WatanabeNicholas Wilcken(University of Sydney)Eric P. Winer(Harvard University Press)William C. Wood(Emory University)
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesMedicineBreast cancerTrastuzumabOncologyCancerDiseaseRadiation therapyInternal medicineSurrogate endpointSystemic therapy
MeSH terms
Breast NeoplasmsCombined Modality TherapyFemaleHumansMastectomyChemotherapy, AdjuvantReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesEarly Detection of CancerPrecision Medicine
Citations
3,672
FWCI
99.72
field-weighted impact
References
136
Percentile
100%
vs. same field & year
Citations per year
Cited by
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
Cancers · 2021 · 1,723 citations
A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers
BMJ Open · 2013 · 382 citations
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2019 · 2,185 citations
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
Breast Cancer Research and Treatment · 2016 · 810 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2010 · 2,860 citations
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Annals of Oncology · 2014 · 1,257 citations
The Latest Research and Development into the Antibody–Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy
Chemical and Pharmaceutical Bulletin · 2019 · 411 citations
Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)
Cancers · 2022 · 508 citations
References
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
British Journal of Cancer · 2007 · 954 citations
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
Radiotherapy and Oncology · 2010 · 628 citations
Comprehensive molecular portraits of human breast tumours
Nature · 2012 · 12,217 citations
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
The Lancet Oncology · 2009 · 1,391 citations
Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO)
International Journal of Radiation Oncology*Biology*Physics · 2009 · 868 citations
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
JNCI Journal of the National Cancer Institute · 2009 · 2,199 citations
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Journal of Clinical Oncology · 2009 · 4,815 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.